Consent timing and experience: modifiable factors that may influence interest in clinical research

Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oncology practice Vol. 8; no. 2; pp. 91 - 96
Main Authors: Gerber, David E, Rasco, Drew W, Skinner, Celette Sugg, Dowell, Jonathan E, Yan, Jingsheng, Sayne, Jennifer R, Xie, Yang
Format: Journal Article
Language:English
Published: United States American Society of Clinical Oncology 01-03-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research. We performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression. Of 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02). Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation.
AbstractList Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research.
PURPOSELow rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research. METHODSWe performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression. RESULTSOf 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02). CONCLUSIONFactors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation.
Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research. We performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression. Of 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02). Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation.
Author Gerber, David E
Sayne, Jennifer R
Xie, Yang
Dowell, Jonathan E
Skinner, Celette Sugg
Rasco, Drew W
Yan, Jingsheng
Author_xml – sequence: 1
  givenname: David E
  surname: Gerber
  fullname: Gerber, David E
  organization: University of Texas Southwestern Medical Center, Dallas, TX
– sequence: 2
  givenname: Drew W
  surname: Rasco
  fullname: Rasco, Drew W
– sequence: 3
  givenname: Celette Sugg
  surname: Skinner
  fullname: Skinner, Celette Sugg
– sequence: 4
  givenname: Jonathan E
  surname: Dowell
  fullname: Dowell, Jonathan E
– sequence: 5
  givenname: Jingsheng
  surname: Yan
  fullname: Yan, Jingsheng
– sequence: 6
  givenname: Jennifer R
  surname: Sayne
  fullname: Sayne, Jennifer R
– sequence: 7
  givenname: Yang
  surname: Xie
  fullname: Xie, Yang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23077435$$D View this record in MEDLINE/PubMed
BookMark eNpVkc1PAyEUxInRqFXP3gxHL1thgVI8mJjGz5joQRNvhGUfFrMLFbZG_3tpqkZPTODHvDeZEdoMMQBCh5SMaU3Iye39w7gmlI4JIYyJDbRLFRMVn6jnzaKF4JXkUu6gUc6vhHCh1GQb7dSMSMmZ2EXNLIYMYcCD7314wSa0GD4WkDwEC6e4j6133jQdYGfsEFPGw9wMuDef2AfXLVdYUQMkyEMR2HY-eGs6XC7AJDvfR1vOdBkOvs899HR58Ti7ru7ur25m53eVZYoNVdNMJ3XdcKrA2RKJ1bwlVoEUXBIqJoSpqWNgXcGNFA3UbStKCMIs541ybA-drX0Xy6aH1pZUyXR6kXxv0qeOxuv_L8HP9Ut814wLOWWiGBx_G6T4tixxdO-zha4zAeIya1qWUlMieV3QkzVqU8w5gfsdQ4leNaNLM3rVjF43U34c_d3ul_-pgn0B-rCNJA
CitedBy_id crossref_primary_10_1016_j_cllc_2019_07_008
crossref_primary_10_1016_j_cct_2022_106922
crossref_primary_10_1177_1740774520939247
crossref_primary_10_1016_j_jtho_2017_07_020
crossref_primary_10_1016_j_cllc_2020_12_001
crossref_primary_10_1007_s13539_014_0128_z
crossref_primary_10_1016_j_cllc_2017_04_012
crossref_primary_10_1097_SLA_0000000000001483
crossref_primary_10_1200_JCO_19_00101
crossref_primary_10_1634_theoncologist_2015_0083
crossref_primary_10_1016_j_conctc_2020_100532
crossref_primary_10_1089_bio_2013_0083
crossref_primary_10_1111_jonm_12248
crossref_primary_10_1093_jnci_djv002
crossref_primary_10_1093_jnci_dju302
crossref_primary_10_1200_JOP_2016_013060
Cites_doi 10.1001/jama.291.22.2720
10.1136/bmj.38366.562685.8F
10.1093/annonc/mdn623
10.1200/JCO.2001.19.6.1728
10.1002/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8
10.1002/cncr.22319
10.1080/02841860600849067
10.1097/00000421-199902000-00011
10.1002/cncr.11213
10.1200/JCO.2003.08.010
10.1002/cncr.22436
10.1200/JCO.2003.02.105
10.1016/S0140-6736(02)07810-8
10.1136/jme.2002.001461
10.1200/JCO.2007.14.8114
10.1200/JCO.2003.08.031
10.1002/cncr.21613
10.1002/cncr.23170
10.1001/jama.292.13.1593
10.1001/jama.1983.03340190048030
10.1016/S0277-9536(00)00178-7
10.1542/peds.85.1.58
10.1093/jnci/83.4.254
10.1001/archinte.167.5.453
10.1200/JCO.2004.02.175
10.1634/theoncologist.2008-0268
10.1016/S0895-4356(97)00240-0
10.1007/BF02599693
10.1016/j.ijrobp.2007.01.051
ContentType Journal Article
Copyright Copyright © 2011 by American Society of Clinical Oncology 2011
Copyright_xml – notice: Copyright © 2011 by American Society of Clinical Oncology 2011
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1200/JOP.2011.000335
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-469X
EndPage 96
ExternalDocumentID 10_1200_JOP_2011_000335
23077435
Genre Journal Article
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: KL2 RR024983
– fundername: NCI NIH HHS
  grantid: P30 CA142543
GroupedDBID ---
18M
29L
2WC
39C
4.4
5GY
5VS
AAQQT
AAWTL
ABDBF
ABJNI
ACGFO
ACGFS
ADBBV
AEGXH
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C45
CS3
DIK
E3Z
EBS
EJD
ESX
F5P
F9R
FBNNL
GX1
H13
HZ~
J5H
KQ8
NPM
O9-
OK1
OVD
P2P
RHF
RHI
RUC
SV3
TEORI
TR2
W8F
WOQ
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c393t-bb8622b419efc011324d0c9e754701560398f3ecfc39a75be2dd574303c44b9f3
ISSN 1554-7477
IngestDate Tue Sep 17 21:28:20 EDT 2024
Sat Aug 17 00:14:12 EDT 2024
Thu Nov 21 21:04:14 EST 2024
Sat Sep 28 08:07:36 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-bb8622b419efc011324d0c9e754701560398f3ecfc39a75be2dd574303c44b9f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc3457835?pdf=render
PMID 23077435
PQID 1113980742
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3457835
proquest_miscellaneous_1113980742
crossref_primary_10_1200_JOP_2011_000335
pubmed_primary_23077435
PublicationCentury 2000
PublicationDate 2012-03-01
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Alexandria, VA
PublicationTitle Journal of oncology practice
PublicationTitleAlternate J Oncol Pract
PublicationYear 2012
Publisher American Society of Clinical Oncology
Publisher_xml – name: American Society of Clinical Oncology
References 2296494 - Pediatrics. 1990 Jan;85(1):58-62
19401521 - Oncologist. 2009 May;14(5):468-75
17200964 - Cancer. 2007 Feb 1;109(3):465-76
15187053 - JAMA. 2004 Jun 9;291(22):2720-6
2795264 - J Gen Intern Med. 1989 Sep-Oct;4(5):410-2
18922881 - Ann Oncol. 2009 Feb;20(2):379-85
18008353 - Cancer. 2008 Jan 1;112(1):212-9
11879860 - Lancet. 2002 Feb 23;359(9307):650-6
11148585 - Cancer. 2001 Jan 1;91(1 Suppl):233-6
12610181 - J Clin Oncol. 2003 Mar 1;21(5):830-5
15542812 - J Clin Oncol. 2004 Nov 15;22(22):4626-31
17353492 - Arch Intern Med. 2007 Mar 12;167(5):453-60
9474067 - J Clin Epidemiol. 1998 Feb;51(2):69-79
15467062 - JAMA. 2004 Oct 6;292(13):1593-601
10025379 - Am J Clin Oncol. 1999 Feb;22(1):42-6
14872080 - J Med Ethics. 2004 Feb;30(1):73-9
12663731 - J Clin Oncol. 2003 Apr 1;21(7):1383-9
12627515 - Cancer. 2003 Mar 15;97(6):1499-506
17078056 - Cancer. 2006 Dec 1;107(11):2669-77
11251003 - J Clin Oncol. 2001 Mar 15;19(6):1728-33
12915605 - J Clin Oncol. 2003 Aug 15;21(16):3141-9
11218181 - Soc Sci Med. 2001 Mar;52(5):797-808
16397866 - Cancer. 2006 Jan 15;106(2):258-70
18509178 - J Clin Oncol. 2008 Jun 1;26(16):2666-73
6632164 - JAMA. 1983 Nov 18;250(19):2646-8
17438704 - Acta Oncol. 2007;46(1):42-8
17418963 - Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1145-50
1994054 - J Natl Cancer Inst. 1991 Feb 20;83(4):254-9
15705666 - BMJ. 2005 Feb 19;330(7488):400
B20
B21
B22
B23
B25
B26
B27
B28
B29
Tarnowski KJ (B24) 1990; 85
B10
B11
B12
B13
B14
B15
B16
B17
B18
B19
B1
B2
B3
B4
B5
B6
B7
B8
B9
References_xml – ident: B3
  doi: 10.1001/jama.291.22.2720
– ident: B17
  doi: 10.1136/bmj.38366.562685.8F
– ident: B21
  doi: 10.1093/annonc/mdn623
– ident: B4
  doi: 10.1200/JCO.2001.19.6.1728
– ident: B8
  doi: 10.1002/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8
– ident: B10
  doi: 10.1002/cncr.22319
– ident: B20
  doi: 10.1080/02841860600849067
– ident: B26
  doi: 10.1097/00000421-199902000-00011
– ident: B7
  doi: 10.1002/cncr.11213
– ident: B5
  doi: 10.1200/JCO.2003.08.010
– ident: B11
  doi: 10.1002/cncr.22436
– ident: B29
  doi: 10.1200/JCO.2003.02.105
– ident: B16
  doi: 10.1016/S0140-6736(02)07810-8
– ident: B28
  doi: 10.1136/jme.2002.001461
– ident: B14
  doi: 10.1200/JCO.2007.14.8114
– ident: B18
  doi: 10.1200/JCO.2003.08.031
– ident: B27
  doi: 10.1002/cncr.21613
– ident: B1
  doi: 10.1002/cncr.23170
– ident: B15
  doi: 10.1001/jama.292.13.1593
– ident: B23
  doi: 10.1001/jama.1983.03340190048030
– ident: B25
  doi: 10.1016/S0277-9536(00)00178-7
– volume: 85
  start-page: 58
  year: 1990
  ident: B24
  publication-title: Pediatrics
  doi: 10.1542/peds.85.1.58
  contributor:
    fullname: Tarnowski KJ
– ident: B2
  doi: 10.1093/jnci/83.4.254
– ident: B19
  doi: 10.1001/archinte.167.5.453
– ident: B6
  doi: 10.1200/JCO.2004.02.175
– ident: B13
  doi: 10.1634/theoncologist.2008-0268
– ident: B12
  doi: 10.1016/S0895-4356(97)00240-0
– ident: B22
  doi: 10.1007/BF02599693
– ident: B9
  doi: 10.1016/j.ijrobp.2007.01.051
SSID ssj0045996
Score 1.6583195
Snippet Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have...
Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward...
PURPOSELow rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 91
SubjectTerms Original Contributions
Title Consent timing and experience: modifiable factors that may influence interest in clinical research
URI https://www.ncbi.nlm.nih.gov/pubmed/23077435
https://search.proquest.com/docview/1113980742
https://pubmed.ncbi.nlm.nih.gov/PMC3457835
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2MvY91n9oUGexgMb7ElV9beRpvSsa4pWwp5M5YsN3moXRrn_9-d9WGnpdA97MUYx1EU3Y_T3enud4R8LBTswZKBW7IvJhEvRRVlBTiuKVNMxqbMtMDi5OM_4nSRHU75dDTyWUv9s_8qaXgGssbK2X-QdhgUHsA9yByuIHW43kvu2IETz_dbbNdl6w9NoDNG__-yKVfVqquY8s122mXRfr4ssATQtSzpaCSwbQfGQ0L1pGMGWt5h0Ta1toxOvvQqJPeA7Cw0uhT6vvrhd7HWXaz28BrZ_UO4p-8IdgDbYtsaUHAXF8Hobnwqt4_9uxFd9ALTQHz61hdjNa5kaQQ--mKokrMB8pKBepXxYKO2nXBvbQGJ7W49O3P8rNitLu13O3_CfzrLj85PTvL5dDHfIQ8S0FOdR_7jp9_IOTLXODYoGPTrjSG3DZlb3snNJNuB1TJ_Qh474dDvFid7ZGTqp-ThL5dQ8YwoBxdq4UIBLrSHyzfag4U6sFAECwWw0AAW6sECN9SDhXqwPCfnR9P5wXHk2m5EmknWRkqBl5soHktTafi_YHKXEy2NSLnoCu-ZzCpmdAWvFyJVJinLFAzRCdOcK1mxF2S3bmrzitBYVrwAgxeNWI5kcDpWKtGTquRKlcKMySe_hvmVZVfJ0StN8Ih1dpbjcud2ucfkg1_jHDQgHmsVtWk2a_RhYUYY4xmTl3bNw2BY5gBTg2-LLWmEF5BdffuTerXsWNZhwhgVfX2P331DHvXYfkt22-uNeUd21uXmfYeov98Vmzc
link.rule.ids 230,315,782,786,887,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Consent+timing+and+experience%3A+modifiable+factors+that+may+influence+interest+in+clinical+research&rft.jtitle=Journal+of+oncology+practice&rft.au=Gerber%2C+David+E&rft.au=Rasco%2C+Drew+W&rft.au=Skinner%2C+Celette+Sugg&rft.au=Dowell%2C+Jonathan+E&rft.date=2012-03-01&rft.eissn=1935-469X&rft.volume=8&rft.issue=2&rft.spage=91&rft.epage=96&rft_id=info:doi/10.1200%2FJOP.2011.000335&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-7477&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-7477&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-7477&client=summon